These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1302 related articles for article (PubMed ID: 2659369)

  • 21. Mycobacterium leprae-specific T cells from a tuberculoid leprosy patient suppress HLA-DR3-restricted T cell responses to an immunodominant epitope on 65-kDa hsp of mycobacteria.
    Haanen JB; Ottenhoff TH; Lai A Fat RF; Soebono H; Spits H; de Vries RR
    J Immunol; 1990 Dec; 145(11):3898-904. PubMed ID: 1701000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
    Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG
    J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delipidified cell components of Mycobacterium leprae and its applications.
    Mahadevan PR; Robinson P; Vermani M; Pardhy A; Joshi S
    Indian J Lepr; 1991; 63(3-4):371-87. PubMed ID: 1804891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of various preparations of Mycobacterium leprae and other mycobacteria by lymphocyte stimulation.
    Bjune G
    Int J Lepr Other Mycobact Dis; 1978; 46(3-4):386-93. PubMed ID: 83309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serological response in leprosy and tuberculosis patients to the 18-kDa antigen of Mycobacterium leprae and antigen 85B of Mycobacterium bovis BCG.
    Vikerfors T; Olcén P; Wiker H; Watson JD
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):571-80. PubMed ID: 8151188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary study of cellular immunity to Mycobacterium leprae protein in contacts and leprosy patients.
    Rada EM; Santaella C; Aranzazu N; Convit J
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):189-94. PubMed ID: 1522361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of T-cell-activating recombinant antigens shared among three candidate antileprosy vaccines, killed M. leprae, M. bovis BCG, and mycobacterium w.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):265-73. PubMed ID: 3045224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A peptidoglycan protein complex purified from M. leprae cell walls contains most or all immunodominant M. leprae T-cell antigens.
    Mutis T; van Schooten WC; de Vries RR
    Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):788-93. PubMed ID: 2681461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recognition of Mycobacterium leprae antigens with antibodies present in sera from patients with lepromatous leprosy.
    Islas-Rodríguez AE; Guillén-Vargas CM; Fafutis-Morris M; Alfaro-Bustamante F; Morales-Ortíz R; Gonzalez-Mendoza A; Estrada-Parra I
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):245-9. PubMed ID: 7690388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. M. leprae recombinant antigens important for T-cell reactivity.
    Mustafa AS
    Indian J Lepr; 1999; 71(1):75-86. PubMed ID: 10439328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T cell epitopes on the 36K and 65K Mycobacterium leprae antigens defined by human T cell clones.
    Van Schooten WC; Ottenhoff TH; Klatser PR; Thole J; De Vries RR; Kolk AH
    Eur J Immunol; 1988 Jun; 18(6):849-54. PubMed ID: 2454825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy.
    Nath I; Sathish M; Jayaraman T; Bhutani LK; Sharma AK
    Clin Exp Immunol; 1984 Dec; 58(3):522-30. PubMed ID: 6391762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgG subclass antibody to Mycobacterium leprae 18,000 MW antigen is restricted to IgG1 and IgG3 in leprosy.
    Hussain R; Dockrell HM; Chiang TJ
    Immunology; 1994 Nov; 83(3):495-500. PubMed ID: 7835976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variation of in vitro lymphocyte responses to M. leprae antigen in borderline tuberculoid leprosy patients.
    Bjune G
    Int J Lepr Other Mycobact Dis; 1980 Mar; 48(1):30-40. PubMed ID: 6154019
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunological profiles of leprosy patients and healthy family contacts toward M. leprae antigens.
    Ilangumaran S; Ramanathan S; Shankernarayan N; Ramu G; Muthukkarauppan V
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):6-14. PubMed ID: 8627115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in T cell signal transduction by M. leprae antigens is associated with downregulation of second messengers PKC, calcium, calcineurin, MAPK and various transcription factors in leprosy patients.
    Chattree V; Khanna N; Rao DN
    Mol Immunol; 2007 Mar; 44(8):2066-77. PubMed ID: 17046060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular immune responses to mycobacterial heat shock proteins in Nepali leprosy patients and controls.
    Roche PW; Theuvenet WJ; Britton WJ
    Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):36-43. PubMed ID: 1602192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cell defect in lepromatous leprosy is reversible in vitro in the absence of exogenous growth factors.
    Mohagheghpour N; Gelber RR; Engleman EG
    J Immunol; 1987 Jan; 138(2):570-4. PubMed ID: 2947952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-DQ molecules and the control of Mycobacterium leprae-specific T cell nonresponsiveness in lepromatous leprosy patients.
    Ottenhoff TH; Walford C; Nishimura Y; Reddy NB; Sasazuki T
    Eur J Immunol; 1990 Oct; 20(10):2347-50. PubMed ID: 1700754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An analysis of in vitro T cell responsiveness in lepromatous leprosy.
    Kaplan G; Weinstein DE; Steinman RM; Levis WR; Elvers U; Patarroyo ME; Cohn ZA
    J Exp Med; 1985 Sep; 162(3):917-29. PubMed ID: 3928804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 66.